Hepatocellular Carcinoma (HCC)_Torisel_

NCT01251458 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Inoperable HCC

Interventions

DRUG: Torisel

Sponsor

Chinese University of Hong Kong